Graham Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $853K | Sell |
41,783
-26,602
| -39% | -$543K | 0.01% | 594 |
|
|
2025
Q1 | $1.37M | Buy |
68,385
+26,709
| +64% | +$535K | 0.02% | 430 |
|
|
2024
Q4 | $1.11M | Buy |
41,676
+26,000
| +166% | +$693K | 0.02% | 439 |
|
|
2024
Q3 | $447K | Buy |
15,676
+824
| +6% | +$23.5K | 0.01% | 634 |
|
|
2024
Q2 | $323K | Buy |
14,852
+2,662
| +22% | +$58K | 0.01% | 680 |
|
|
2024
Q1 | $270K | Sell |
12,190
-2,690
| -18% | -$59.6K | 0.01% | 799 |
|
|
2023
Q4 | $321K | Buy |
+14,880
| New | +$321K | 0.01% | 683 |
|
|
2023
Q2 | – | Sell |
-31,011
| Closed | -$705K | – | 1002 |
|
|
2023
Q1 | $705K | Buy |
31,011
+4,076
| +15% | +$92.6K | 0.02% | 624 |
|
|
2022
Q4 | $634K | Sell |
26,935
-17,862
| -40% | -$420K | 0.02% | 679 |
|
|
2022
Q3 | $1.17M | Sell |
44,797
-28,875
| -39% | -$753K | 0.05% | 412 |
|
|
2022
Q2 | $1.62M | Buy |
+73,672
| New | +$1.62M | 0.07% | 272 |
|